文传商讯
Boehringer Ingelheim receives approval for SENVELGO in Europe: the first oral liquid medication for
2023-11-27 17:46:32
Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer ther
2023-11-27 17:46:32
FGS Global Acquires Longview, the Leading Canadian Communications and Public Affairs Firm
2023-11-22 22:31:52
Galderma Reports Record Net Sales of Over 3 B USD for the First Nine Months of 2023 With Strong Grow
2023-11-22 22:31:52
